Crossbow Therapeutics raised $77M in a Series B
Crossbow Therapeutics raised $77M in a Series B
| Investor | Firm Type | Partner |
|---|---|---|
| Private |
| — |
Arkin HoldingsLEAD | Private | — |
Taiho VenturesLEAD | Venture Capital | — |
| Venture Capital | — |
Pini OrbachLEAD | Angel | Pini Orbach |
Sakae AsanumaLEAD | Angel | Sakae Asanuma |
| Venture Capital | — |
| Venture Capital | — |
| Foundation | — |
| Venture Capital | — |
| Venture Capital | — |
| Public | — |
| Hedge Fund | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Angel | Eli Lilly |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$157M
Top Valuation
-
Crossbow Therapeutics raised $77M in a Series B round.
The round was led by Taiho Ventures, Arkin Bio Ventures, Sakae Asanuma, Pini Orbach, Pini Orbach, Sakae Asanuma.